COVID-19 Drugs: Materials for Clinical Research, Drug Development and TDM
- > Human-matrix based calibrators and quality control material for
9 drug candidates & metabolites
- > Reliable protocol for monitoring of these drugs in plasma/serum available*
Researchers are working furiously to test a variety of potential drugs to find a suitable treatment for COVID-19, the disease caused by SARS-CoV-2. To support laboratories with this challenge, Chromsystems offers calibrator and control material of drug candidates, aimed at supporting your clinical research. We as assay manufacturer are aware of our duty to quickly supply material of highest quality. We ensure that the 3PLUS1® calibrator and MassCheck® controls are produced with a maximum of quality to support your efforts in the best possible way.
Approximate range of level 1-3
730 - 2130
(active metabolite of Remdesivir)
|22-95||35 - 67|
|Lopinavir||390-6300||1070 - 4970|
|Ritonavir||95-6250||770 - 4940|
|Favipiravir||3291-10400||2680 - 7980|
|Chloroquine||18-450||110 - 350|
|Hydroxychloroquine||460-1150||470 - 940|
|Nafamostat||2-200||45 - 170|
|Azithromycin||40-440||150 - 350|
We also developed a test protocol to ensure that all analytes can be measured reliably with MassTox® TDM Series A*, our modular solution for the therapeutic drug monitoring (TDM) of more than 200 drugs. Existing users can simply use the same chromatographic set up, sample prep and MasterColumn®. All you need are a few additional components from MassTox® TDM Series A as described in the application note here.
The chromatographic setup of MassTox® TDM Series A can be used to determine these drugs quickly and safely.
COVID-19 Drugs - Quality Controls:
|0268||MassCheck® COVID-19 Drugs Plasma Control Level I|
|0269||MassCheck® COVID-19 Drugs Plasma Control Level II|
COVID-19 Drugs - Calibrator Material:
|92055||3PLUS1® Multilevel Plasma Calibrator Set COVID-19 Drugs|
In case you have any questions or need more information please contact us.